Morgan Stanley has recently raised Gilead Sciences Inc (GILD) stock rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock ...
Situated in Foster City, California, Gilead Sciences, Inc. (GILD) is a top biopharmaceutical company specializing in the ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Legend Biotech Corporation (NASDAQ:LEGN) has been making waves in the biotechnology sector with its flagship product, ...
Zacks.com on MSN23h
Top Stock Reports for Salesforce, Shell, Gilead Sciences & OthersToday's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Shell plc (SHEL) and Gilead Sciences, Inc. (GILD).
While the deals done this week are important for the future direction of the industry – US company Gilead (US:GILD) inked the biggest, paying up to $1.7bn for Leo Pharma’s range of pre-clinical ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Discover investment opportunities in lesser-covered stocks like Arcus Biosciences, Sarepta Therapeutics, and Edison International.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback